Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease
China
Sponsor: AstraZeneca
Neurofibromatosis 1 · Neurofibroma, Plexiform
South Korea
- Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.Recruiting
Sponsor: AstraZeneca
Lupus Erythematosus, Systemic
Italy
- The Fontan Dapagliflozin Pilot StudyCompleted
Sponsor: Johns Hopkins University
Heart Failure
United States
- Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care SettingActive Not Recruiting
Sponsor: AstraZeneca
Pulmonary Disease, Chronic Obstructive
Canada, Germany, Greece, Italy, Japan +2 more
- iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic DiseasesRecruiting
Sponsor: AstraZeneca
Type 2 Diabetes · Hypertension · Chronic Kidney Disease · Heart Failure
Brazil, Chile, Costa Rica, Côte d’Ivoire, Egypt +15 more
Sponsor: AstraZeneca
Rare Diseases · Neuromyelitis Optica Spectrum Disorder (NMOSD)
Russia
Sponsor: AstraZeneca
RSV Respiratory Syncytial Virus
United States
Sponsor: AstraZeneca
Eosinophilic Granulomatosis With Polyangiitis (EGPA) · Hypereosinophilia Syndrome (HES)
United States, Brazil, Canada, France, India +5 more
Sponsor: AstraZeneca
Advanced or Metastatic Non-small Cell Lung Cancer
United States, Belgium, Brazil, China, France +15 more
Sponsor: AstraZeneca
Viral Lung Infection and Acute Respiratory Failure
United States, Argentina, Australia, Belgium, Brazil +34 more
- Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLCActive Not Recruiting
Sponsor: AstraZeneca
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
United States, Argentina, Australia, Austria, Belgium +21 more
Sponsor: Canadian Cancer Trials Group
Ovarian Cancer
United States, Canada
Sponsor: AstraZeneca
Epithelial Ovarian Cancer
United States, Australia, Belgium, Brazil, Canada +19 more
- Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of ExacerbationsRecruiting
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease · COPD
France
- Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic Breast Cancer.Not Yet Recruiting
Sponsor: UNICANCER
Metastatic Invasive Breast Cancer
Sponsor: Idoven 1903 S.L.
Heart Failure · Cardiovascular Risk Factors
Spain, Sweden
- Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsiaRecruiting
Sponsor: AstraZeneca
Neurofibromatosis
Russia
Sponsor: AstraZeneca
Asthma
United States, Argentina, Brazil, Chile, China +16 more
Sponsor: AstraZeneca
Carcinoma, Non-Small-Cell Lung
United States, Australia, Belgium, Brazil, Canada +15 more
- A Study in Participants With Obesity or Overweight With at Least One Weight-related ComorbidityCompleted
Sponsor: AstraZeneca
Obesity or Overweight
United States, Australia, Canada, Japan, United Kingdom
Sponsor: AstraZeneca
Hypophosphatasia
Russia
- Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in ItalyActive Not Recruiting
Sponsor: AstraZeneca
Asthma
Italy
- AZD9291 in Combination With Ascending Doses of Novel TherapeuticsActive Not Recruiting
Sponsor: AstraZeneca
Advanced Non Small Cell Lung Cancer
United States, Canada, Japan, Poland, Russia +3 more
Sponsor: AstraZeneca
Acute Lymphoblastic Leukaemia · Acute Myeloid Leukaemia · Higher-risk Myelodysplastic Syndromes
United States, Australia, Canada, Denmark, Germany +4 more